scholarly journals Personification of nordic walking course in children with bronchial asthma depending on physical health level and disease control

2021 ◽  
Vol 37 (6) ◽  
pp. 48-53
Author(s):  
E. N. Kuzina ◽  
E. M. Spivak ◽  
N. N. Nezhkina

Objective. To evaluate the effectiveness of a personalized Nordic walking course in children with bronchial asthma. Material and methods. In conditions of a local sanatorium, 60 children aged 814 years with atopic bronchial asthma in remission were examined, 30 patients received the usual set of health-improving measures (comparison group), 30 patients additionally underwent a course of sports walking, personalized depending on the degree of asthma control and the level of physical health (main group). To evaluate it, the method of L.G. Apanasenko was used. Indicators of external respiration, abdominal and back muscle strength, physical performance, and Robinson and Rufier indices were determined. The children were examined twice: before and after the rehabilitation course. The dynamics of functional indicators was expressed as a percentage increase in relation to the initial values. Results. It was found that 36.7 % of patients had a low, 53.3 % average and only 10 % high level of physical health. Only 10 % had a complete asthma control, and 90 % of children had a partial control. The use of a personalized sports walking course helped to improve the functional parameters of external respiration, muscular and cardiovascular systems. In the comparison group, the positive dynamics of most of functional indicators was significantly less obvious. Conclusions. The course of Nordic walking in children with bronchial asthma at the stage of rehabilitation should be personalized taking into account the level of physical health and the degree of disease control. This technology in this category of patients has a significant positive health-strengthening effect, which is manifested by improving the functional state of the muscular, respiratory and cardiovascular systems.

2012 ◽  
Vol 9 (1) ◽  
pp. 42-49
Author(s):  
E A Sobko ◽  
A Y Kraposhina ◽  
O P Ischenko ◽  
I V Demko ◽  
A B Salmina ◽  
...  

Background. The objective of this study was to estimate a vascular wall status of large arteries and function of endothelium in patients with different clinical forms of bronchial asthma throughout the disease progression. 220 patients with bronchial asthma have been examined, including 106 persons with moderate asthma ( 1 st group), 61 persons with severe asthma (2 nd group), and 53 persons with steroid-dependent asthma. Control group was formed from 40 healthy donors. Methods. We have assessed parameters of external respiration, arterial rigidity, and the levels of TNFα, IL-6, sCD31 (sPECAM-1), CRP in the peripheral blood at the time of exacerbation and 48 weeks later. Results. We found elevation of IL-6 and TNFα levels in all the tested groups in the period of exacerbation comparing to the control group (p


2020 ◽  
Vol 15 (5) ◽  
pp. 102-109
Author(s):  
A.V. Kamaev ◽  
◽  
O.V. Trusova ◽  
I.A. Kamaeva ◽  
N.L. Lyashenko ◽  
...  

Background. Children with mild bronchial asthma (BA) are prone to poor control of symptoms during seasonal acute respiratory infections (ARIs). Objective. To optimize therapy in children with mild BA to improve disease control during seasonal ARIs. Patients and methods. This single-blind placebo-controlled prospective single-center trial evaluating the efficacy of ammonium glycyrrhizinate (Reglisam, ‘VIFITECH,’ Russia) and lasting 4 months included 63 children with mild BA (21 in the placebo group) aged 5 to 10 years with a disease duration of at least 3 months. We assessed respiratory function, FeNO level, results of the asthma control test, characteristics of BA exacerbations, and the need for betamimetics and budesonide via a nebulizer. We used the Student's t-test and Wilcoxon test to evaluate the differences in mean and median values; the differences were considered significant at р < 0.05. Results. The frequency and mean duration of ARIs were lower in the group of active therapy (1.06 ± 0.35 episodes and 6.52 ± 2.19 days) than in the placebo group (1.77 ± 0.26 episodes and 10.83 ± 3.07 days). The differences were statistically significant (р = 0.036 and р = 0.019, respectively). Patients receiving placebo required longer budesonide administration per one BA exacerbation: 11.72 ± 1.98 days vs 8.65 ± 2.17 days in patients receiving active therapy (р = 0.026). Significant differences in the respiratory function and FeNO level were observed only in the subgroup of patients who had incomplete asthma control upon enrollment. We observed no new adverse events that had not been reported earlier. Conclusion. Our findings suggest high efficacy of ammonium glycyrrhizinate used to enhance basic therapy for mild BA in children, in whom respiratory infections are the most common triggers of BA exacerbations. Key words: ammonium glycyrrhizinate, basic therapy, children, mild bronchial asthma, acute respiratory infections (ARIs)


2015 ◽  
Vol 4 (2) ◽  
pp. 10-12
Author(s):  
Dmitry Alexandrovich Anisimov ◽  
Lyudmila Nikitichna Goncharov ◽  
Anna Albertovna Dyachkova

Respiratory failure (NAM)-a pathological condition in which there is provided the maintenance of normal blood gas or it is achieved through more intensive operation of external respiration and heart, resulting in decreased functional capacity of the organism [1,2]. The main method of diagnosis of DN is the study of the gas composition of the arterial blood, but because of the complexity of the analysis, which involves complex invasive techniques for obtaining arterial blood by puncture of a major artery in the therapeutic Department is not carried out [1,3]. A plurality of classifications days, the lack of clear criteria for diagnosis was to analyze assessment days by a combination of clinical, laboratory and instrumental methods patient days. As a model of acute respiratory failure were selected from patients with mild intermittent and persistent severity of asthma, which bore a slight aggravation, burdened days 1 severity, number of 30 people. SatO2 blood was the criterion for assessing the severity of DN. In the evaluation of clinical parameters, such as shortness of breath and respiratory rate, it was revealed that the values of these parameters increase is inversely proportional to the drop SatO2 blood. In assessing such clinical parameters as the rate of breathing and instrumental measure FEV1 did not find such dependence. Thus, to assess the severity of DN in patients with bronchial asthma it is necessary to conduct a comprehensive analysis of the clinical and instrumental methods.


2019 ◽  
Vol 18 (4) ◽  
pp. 488-496
Author(s):  
Abbas Fadaii ◽  
Ali Majidpour ◽  
Somayeh Soleymanzadeh Moghadam ◽  
Hamideh Rahmani Seraji ◽  
◽  
...  

2020 ◽  
Vol 8 (4) ◽  
pp. 383-392
Author(s):  
О.К. Koloskova ◽  
Т.М. Bilous ◽  
N.O. Shevchenko ◽  
V.V. Bilous

Despite the large number of studies on the diagnosis and treatment of asthma and the constant updating of recommendations for the provision of medical care to patients with asthma, this disease still has a significant impact on the quality of life of patients and their families and significant economic losses. However, the peculiarities of bronchial asthma and the diagnosis of certain phenotypes of the disease in children, depending on biomarkers of inflammatory activity in the airways, require greater use of non-invasive diagnostic procedures and optimization of individualized treatment depending on the nature and intensity of inflammation in the respiratory tract.


1998 ◽  
Vol 79 (4) ◽  
pp. 282-285
Author(s):  
A. M. Potemkin ◽  
T. V. Klykova ◽  
I. A. Blonde

The data on the frequency of revealing the bronchial permeability disorders are presented and the mechanisms of its development in children with atopic dermatitis not having clinically bronchoobstructive syndrome in anamnesis are studied. In children with atopic dermatitis the main risk factors of the bronchial asthma development are shown and the possibilities of revealing its early preclinical signs are determined. It is significant in prevention of the bronchial asthma development in timely performance of specific preventive measures.


Author(s):  
Barno Turdikhodjaevna Khalmatova ◽  
Gulnoza Aloyevna Tashmatova ◽  
Nargis Khayrullayevna Mirsalikhova

2020 ◽  
Vol 29 (6) ◽  
pp. 725-733
Author(s):  
O. Yu. Kytikova ◽  
M. V. Antonyuk ◽  
B. I. Gel'tser ◽  
E. E. Mineeva ◽  
T. A. Gvozdenko

The small respiratory passages dysfunction (SRPD) is found in the vast majority of patients with bronchial asthma (BA). The SRPD is currently recognized as the important pathogenetic feature of BA. The purpose of this review is to analyze the current scientific knowledge about the poorly studied aspects of the small respiratory passages (SRR) participation in the development of pathological process in BA, as well as the impact of small bronchial dysfunction on the clinical course, the exacerbation frequency and the disease control. The importance of SRPD diagnostics in BA patients for optimal and timely treatment is discussed. The modern methods of RPD pathology diagnostics are described; their informative use in the comparative study aspect is considered.


Sign in / Sign up

Export Citation Format

Share Document